The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Provides tools for importing and cleaning Experience Sampling Method (ESM) data collected via the 'm-Path' platform. The goal is to provide with a few utility functions to be able to read and perform some common operations in ESM data collected through the 'm-Path' platform (<https://m-path.io/landing/>). Functions include raw data handling, format standardization, and basic data checks, as well as to calculate the response rate in data from ESM studies.
Version: | 1.0.2 |
Depends: | R (≥ 4.0.0) |
Imports: | cli, dplyr, ggplot2, jsonlite, lifecycle, lubridate, readr, rlang, tidyr |
Suggests: | knitr, rmarkdown, spelling, testthat (≥ 3.0.0) |
Published: | 2024-11-22 |
DOI: | 10.32614/CRAN.package.mpathr |
Author: | Merijn Mestdagh [aut, cre], Lara Navarrete [aut], Koen Niemeijer [aut], m-Path Software [cph] |
Maintainer: | Merijn Mestdagh <merijn.mestdagh at m-path.io> |
BugReports: | https://github.com/m-path-io/mpathr/issues |
License: | GPL (≥ 3) |
URL: | https://m-path.io, https://github.com/m-path-io/mpathr |
NeedsCompilation: | no |
Language: | en-US |
Citation: | mpathr citation info |
Materials: | README NEWS |
CRAN checks: | mpathr results |
Reference manual: | mpathr.pdf |
Vignettes: |
mpathr (source, R code) |
Package source: | mpathr_1.0.2.tar.gz |
Windows binaries: | r-devel: mpathr_1.0.2.zip, r-release: mpathr_1.0.2.zip, r-oldrel: mpathr_1.0.2.zip |
macOS binaries: | r-release (arm64): mpathr_1.0.2.tgz, r-oldrel (arm64): mpathr_1.0.2.tgz, r-release (x86_64): mpathr_1.0.2.tgz, r-oldrel (x86_64): mpathr_1.0.2.tgz |
Old sources: | mpathr archive |
Please use the canonical form https://CRAN.R-project.org/package=mpathr to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.